-
521
Quantitative Liver Function Tests: A Realizable Goal?
Published 1991-01-01“…So far no single test or group of tests has proved to be a sufficiently sensitive and accurate measure of overall hepatic function across the whole spectrum of liver disease. This may he due to diversity in the hepatic handling of these compounds and in changes in architecture, hemodynamics and cell function in liver disease. …”
Get full text
Article -
522
The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
Published 2012-01-01Get full text
Article -
523
Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
Published 2013-01-01“…We observed that the alcoholic chronic liver disease had less antibody response (44%) than other causes of chronic liver disease such as cryptogenic 69% and HCV 75%. …”
Get full text
Article -
524
Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
Published 2019-01-01Get full text
Article -
525
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
Published 2025-01-01“…Compared to traditional therapies, they offer significant advantages in the treatment of liver disease by improving outcomes and reducing side effects. …”
Get full text
Article -
526
Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice
Published 2020-09-01“…Due the increasing number of alcoholic fatty liver disease cases in the world, the development of methods for treating this disease is an urgent task. …”
Get full text
Article -
527
Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data
Published 2025-01-01“…Except for liver disease, all underlying diseases were associated with mortality. …”
Get full text
Article -
528
Penyeimbangan Kelas SMOTE dan Seleksi Fitur Ensemble Filter pada Support Vector Machine untuk Klasifikasi Penyakit Liver
Published 2023-12-01“…Classification of liver disease in patients needs to be done well because the results can help in the initial diagnosis of whether a patient has liver disease. …”
Get full text
Article -
529
Wilson’s Disease and Autoimmune Hepatitis Coexistence: A Cause of Diagnostic Delay
Published 2023-09-01“…Wilson’s disease, although rare, should be suspected in patients with decompensated liver disease. The dominance of clinical and epidemiological features of autoimmune hepatitis as a common causative pathology for chronic liver disease in young and middle-aged ladies may hide the presence of other serious different pathologies such as Wilson’s disease. …”
Get full text
Article -
530
Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik
Published 2015-01-01“…<p>Abstrak<br />Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease) merupakan kondisi klinis yang sering ditemukan dalam bidang hepatologi. …”
Get full text
Article -
531
Liver Cell Death: Update on Apoptosis
Published 2003-01-01“…Hepatocyte cell death is a cardinal feature of almost every liver disease. Apoptosis is a mode of cell death characterized by specific morphological and biochemical features. …”
Get full text
Article -
532
Role of NKT Cells in the Pathogenesis of NAFLD
Published 2012-01-01“…Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease and shows various inflammatory changes in the liver. …”
Get full text
Article -
533
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
Published 2017-05-01“…Objectives To examine the association between coffee, including caffeinated and decaffeinated coffee, with hepatocellular carcinoma (HCC) and assess the influence of HCC aetiology and pre-existing liver disease.Design We performed a systematic review and meta-analysis. …”
Get full text
Article -
534
-
535
Case of acute drug-induced hepatitis after halothane anesthesia
Published 2013-05-01“…The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. …”
Get full text
Article -
536
Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic r...
Published 2025-02-01“…IntroductionDirect antiviral agents (DAAs) have dramatically changed the landscape of liver diseases associated with chronic hepatitis C virus (HCV) infection. …”
Get full text
Article -
537
Large annotated ultrasound dataset of non-alcoholic fatty liver from Saudi hospitals for analysis and applicationsOpen Science framework or (OSF)
Published 2025-02-01“…This study presents a comprehensive ultrasound image dataset for Non-Alcoholic Fatty Liver Disease (NAFLD), addressing the critical need for standardized resources in AI-assisted diagnosis. …”
Get full text
Article -
538
HIV Infection and TLR Signalling in the Liver
Published 2012-01-01“…Despite the availability of effective combination antiretroviral therapy (cART), liver disease is one of the leading causes of morbidity and mortality in Human Immunodeficiency Virus (HIV)-infected individuals, specifically, in the presence of viral hepatitis coinfection. …”
Get full text
Article -
539
Hepatocellular Carcinoma in a 24-Year-Old Female with Beckwith–Wiedemann Syndrome: A Case Report and Review of the Literature
Published 2020-01-01“…Although HCC typically occurs in elderly adults or those with underlying liver disease, in this case, we show that HCC can occur in a young adult with BWS without any underlying liver disease.…”
Get full text
Article -
540
Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
Published 2022-01-01“…In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver fibrosis-specific drug therapy and treatment for metabolic syndrome-related diseases. …”
Get full text
Article